Physician profile
Thomas Agesen
NPI 1497782940
$6,945.37
in general payments reported to CMS, 2019-2025
44 companies · $851 in 2025
The $851 reported for 2025 was more than what 86% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $989 · 2020: $1,029 · 2021: $1,308 · 2022: $925 · 2023: $862 · 2024: $981 · 2025: $851.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,694.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,694.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,194.69 | 2019-2025 | Relistor |
| Collegium Pharmaceutical, INC. | $746.96 | 2019-2025 | Xtampza |
| Abbvie INC. | $689.83 | 2021-2025 | Ubrelvy, Qulipta, Botox |
| Scilex Pharmaceuticals INC. | $450.23 | 2020-2025 | Ztlido |
| Arbor Pharmaceuticals, INC. | $442.71 | 2019-2022 | |
| Biodelivery Sciences International, INC. | $354.32 | 2019-2021 | |
| Protega Pharmaceutials INC | $287.84 | 2022-2025 | Roxybond |
| Azurity Pharmaceuticals, INC. | $259.37 | 2023-2025 | Horizant, Horizant |
| Allergan, INC. | $247.68 | 2019-2022 | |
| Ibsa Pharma INC. | $202.48 | 2020-2023 | Tirosint, Licart |
| Alphatec Spine, INC | $185.96 | 2024 | Invictus Mis |
| Pacira Therapeutics, INC. | $178.40 | 2019-2021 | |
| Redhill Biopharma INC. | $156.34 | 2020-2022 | |
| Daiichi Sankyo INC. | $151.82 | 2019 | |
| Depuy Synthes Sales INC. | $135.97 | 2019-2025 | Orthovisc, Monovisc |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Agesen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.